| Title | Safety and efficacy of ibutilide in heart transplant recipients. | | Author(s) | Tallaj JA, Franco V, Rayburn BK, Pamboukian SV, Benza RL, Kirklin JK, McGiffin DC, Smallfield M, Bourge RC | | Institution | Division of Cardiovascular Disease, Section of Heart Failure, Transplantation and Pulmonary Vascular Disease, University of Alabama at Birmingham, Birmingham, AL 35294, USA. jtallaj@uab.edu | | Source | J Heart Lung Transplant 2009 May; 28(5):505-7. | | Abstract | In this report we describe our experience with ibutilide, a relatively new Class III anti-arrhythmic agent, in 8 heart transplant patients with supraventricular tachycardia in various settings (3 patients with rejection, 2 after endomyocardial biopsy). Ibutilide treatment was successful in all patients, with the arrhythmia recurring early in 1 patient. There were no complications. | | Language | eng | | Pub Type(s) | Journal Article
| | PubMed ID | 19416781 |
|
